Royal Bank Of Canada Vor Biopharma Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 55 shares of VOR stock, worth $47. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$47

% of portfolio

0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.7 - $1.1 $38 - $60	55 New	55 $0
Q1 2024 Nov 05, 2024	BUY	$1.8 - $2.85 $1,566 - $2,479	870 New	870 $2,000
Q1 2024 May 15, 2024	SELL	$1.8 - $2.85 $24,121 - $38,192	-13,401 Reduced 93.9%	870 $2,000
Q4 2023 Feb 14, 2024	BUY	$1.66 - $2.63 $11,822 - $18,730	7,122 Added 99.62%	14,271 $32,000
Q3 2023 Nov 14, 2023	BUY	$2.1 - $3.35 $6,757 - $10,780	3,218 Added 81.86%	7,149 $15,000
Q2 2023 Aug 14, 2023	BUY	$3.09 - $5.33 $12,146 - $20,952	3,931 New	3,931 $12,000
Q4 2022 Feb 14, 2023	SELL	$3.77 - $7.43 $2,767 - $5,453	-734 Reduced 46.69%	838 $5,000
Q3 2022 Nov 14, 2022	BUY	$3.9 - $5.52 $6,130 - $8,677	1,572 New	1,572 $6,000
Q2 2022 Aug 15, 2022	SELL	$3.89 - $6.44 $4,535 - $7,509	-1,166 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.04 - $12.23 $16,012 - $32,421	-2,651 Reduced 69.45%	1,166 $7,000
Q4 2021 Feb 14, 2022	BUY	$11.32 - $18.02 $21,677 - $34,508	1,915 Added 100.68%	3,817 $44,000
Q3 2021 Nov 15, 2021	BUY	$12.24 - $20.38 $13,721 - $22,845	1,121 Added 143.53%	1,902 $30,000
Q2 2021 Aug 16, 2021	BUY	$18.65 - $38.78 $14,565 - $30,287	781 New	781 $15,000

Others Institutions Holding VOR

# of Institutions

Shares Held

41.2M

Call Options Held

9.3K

Put Options Held

100

Ra Capital Management, L.P. Boston, MA

22.7M
Shares

$19.8 Million
0.22% of portfolio
5 Am Venture Management, LLC San Francisco, CA

6.36M
Shares

$5.53 Million
1.77% of portfolio
Hudson Bay Capital Management LP Greenwich, CT

2.47M
Shares

$2.15 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

1.95M
Shares

$1.7 Million
0.0% of portfolio
Cowen And Company, LLC

1.22M
Shares

$1.06 Million
0.02% of portfolio

View Full List

About Vor Biopharma Inc.

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $33.1M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

More about VOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account